Why Moderna Stock Is Plummeting Today
Shares of (NASDAQ: MRNA) are falling on Monday. The company's stock lost 7.9% as of 1:30 p.m. ET and was down as much as 13.9% earlier in the day. The steep decline comes as the S 500 and Nasdaq Composite lost 0.4% and 1.1%, respectively.
The vaccine maker's shares tumbled following the resignation of a key U.S. Food and Drug Administration (FDA) official who oversaw vaccine approvals.
Peter Marks, who led the FDA's Center for Biologics Evaluation and Research (CBER), resigned Friday. As the head of CBER, Marks was critical in the rapid approval of COVID-19 vaccines during the pandemic and, more recently, was heavily involved in the regulator's oversight of cutting-edge cell and gene therapies.
Source Fool.com
Moderna Inc. Stock
€25.48
1.150%
With 9 Buy predictions and 10 Sell predictions the community is currently undecided on Moderna Inc..
A slightly negative potential of -13.64% at a current price of 25.48 € for Moderna Inc. is the result of a target price of 22 €.
